Wearable Acoustic System for Real-Time Prediction and Prevention of Bone Fractures

This invention is a wearable system that continuously monitors bone health using acoustic emission sensors placed directly on a patient's body. By capturing the microscopic crackling noises generated as a bone nears failure, the technology accurately forecasts and alerts the patient before a catastrophic fracture occurs.

Description

The technology operates by detecting acoustic emissions (AE); ultrasonic crackling sounds - that naturally occur within quasi-brittle materials like bone as they experience a progression toward structural failure. The system utilizes one or more wearable AE sensors (such as piezoelectric transducers or microphones) paired with reference sensors placed to minimize background noise. These sensors maintain constant acoustic connection with the bone over a prolonged duration to capture data on cumulative acoustic energy, total events, and amplitude rates in real time. The captured data is evaluated by specialized software algorithms stored in electronic circuitry, such as a connected personal smartphone or a customized processing unit. The system calculates the rate and amplitude of variables, projecting a declining trend line where the inverse AE energy rate approaches zero. This analysis predicts the remaining loading cycles and time to failure under the patient’s typical movement conditions, enabling a dynamic warning system that signals when loading must cease to prevent structural collapse.

Applications

- Monitoring bone health in patients with osteoporosis to anticipate fracture risk before clinical symptoms arise.
- Assessing bone integrity in cancer patients with metastatic bone disease, where early fracture prediction is critical.
- Supporting post-operative rehabilitation by providing continuous feedback on bone healing status following orthopedic surgeries.
- Use in clinical trials to objectively assess the efficacy of bone-strengthening therapeutics and interventions through non-invasive monitoring.
- Integration into personalized healthcare platforms to enable remote bone health management and reduce hospital visits.
- Providing clinicians with a diagnostic tool for early-stage detection of bone degradation in at-risk populations.

Advantages

- Non-Invasive Continuous Monitoring: The wearable form factor enables long-term, real-time assessment without discomfort or disruption to patient activities.
- Early Fracture Prediction: By detecting micro-damage signals before overt fractures occur, the system facilitates timely preventative actions, improving patient outcomes.
- High Sensitivity and Specificity: Advanced signal processing reduces noise interference, increasing the reliability of acoustic emission data interpretation.
- Adaptability: Modular sensor design allows customization for different anatomical sites and disease states, accommodating a broad patient demographic.
- Enhanced Patient Engagement: Real-time alerts empower patients to manage their bone health proactively in collaboration with healthcare providers.
- Data Integration Capability: Compatibility with personal electronic devices promotes seamless data collection, storage, and remote clinical review.

Invention Readiness

The technology has progressed through prototype development stages, including experimental validation of the acoustic emission detection capability and initial signal processing methods to enhance data accuracy. Current efforts focus on refining system integration, optimizing wearable sensor ergonomics, and conducting comprehensive clinical studies to further validate predictive algorithms. Future studies will emphasize large-scale clinical trials to establish efficacy, safety, and user compliance under real-world conditions, alongside advancement toward regulatory clearances and commercial deployment.

IP Status

Patent Pending

Quick Facts:
Reference Number
07401
Technology Type
Medical Device
Technology Subtype
Monitoring Medical Device
Therapeutic Areas
MusculoskeletalOncology
Therapeutic Indications
OsteoporosisProstate cancer / adenocarcinoma
Tags
Personalized Medicine
Lead Inventor
Andrew Bunger
Department
Civil & Environmental Engineering
All Tech Innovators
Andrew P. BungerLan Gardner CoffmanCharles Clemenes HagerWilliam Harbert
Technology Readiness Level
5. Advanced prototype validation
Date Submitted
2025-11-04
Collections
Regenerative MedicineWomen's & Reproductive Health